rovelizumab
... that informed consent for Icos's experimental drug rovelizumab (LeukArrest) was waived during clinical trials if the patient was unconscious and had a high chance of dying?
... that <a href="./Informed_consent" id="mwE1s" rel="mw:WikiLink" title="Informed consent">informed consent</a> for <a href="./Icos" id="mwE1w" rel="mw:WikiLink" title="Icos">Icos</a>'s experimental drug <b id="mwE10"><a href="./Rovelizumab" id="mwE14" rel="mw:WikiLink" title="Rovelizumab">rovelizumab</a></b> (LeukArrest) was waived during <a href="./Clinical_trial" id="mwE18" rel="mw:WikiLink" title="Clinical trial">clinical trials</a> if the patient was unconscious and had a high chance of dying?